APR Applied Pharma Research S.A. and Hao Le Ku (Beijing) Infant and Materniity Co., Ltd. Announce the Signature of a License Agreement for the Distribution and Marketing of the HALYKOO Line in China.
BEIJING & BALERNA, Switzerland–(BUSINESS WIRE)–APR Applied Pharma Research S.A. (“APR”), the Swiss, independent
developer of science driven, patent protected healthcare products, and
Hao Le Ku (Beijing) Infant and Materniity Co., Ltd. (“HLK”), a
Chinese marketing company specialized in baby products, today announced
the start of a partnership for the promotion, distribution and marketing
of the Halykoo baby healthcare product line in China.
Thanks to this license agreement, APR will introduce its Halykoo brand
also in the greater China, including Hong Kong Macau and Taiwan, thus
further expanding the distribution across the world, which next year
will cover many countries in Europe and Australia. This collaboration is
the confirmation of the strong appeal that Halykoo offers to the
international pediatric arena, due to its distinctive positioning in the
market.
This partnership will strengthen HLK position in the baby market
segment, allowing the company to compete in a highly attractive market
through the offer of an innovative brand as Halykoo, which sets a very
new pace in the pediatric healthcare market by providing problem
solution products in smart and tailored delivery formats for happier
kids and more confident moms and caregivers.
“We are very pleased to seize this opportunity to launch the Halykoo
range in China – “said Mr. Ricky Ren CEO of HLK – “and very much agreed
with Halykoo’s brand spirit: Research with babies in mind. This
perfectly matches our company’s long-term goal for the Chinese Market.
We are confident our parents will enjoy Halykoo products and grow with
their children healthily”.
HLK Marketing Director Mr. Fang Geng stated that: “The Chinese baby
product market, accounting for 3% of Chinese GDP, has been growing to
over 2000 Billion RMB in 2015. The Chinese government has abandoned “One
Child Policy”, consequently we believe the next decade will be the
golden stage for new baby boom. With 5 years of research and development
from industry leading R&D laboratory APR, we reckon Halykoo products
will be perfect fit for our market, as we are convinced that every
Chinese baby deserves the world’s most advanced infant care products as
well as every mother should get access to the world most advanced
parenting concept”.
Over the last 20 years, APR has developed high-quality products
certified according to the strictest international regulations. “We are
very happy to welcome HLK into Halykoo international partner network, as
it’s a very dynamic and groundbreaking player which in our opinion has
the necessary qualifications to successfully launch Halykoo brand in the
Chinese market” said Paolo Galfetti, CEO and co-founder of APR”. “No
need to say we are extremely satisfied that our brand will soon peep out
outside Europe, proving its unique and internationally valuable selling
proposition”.
About Halykoo
Halykoo is a new global brand in the pediatric
self-care market, conceived and developed by APR starting from an unmet
demand driven insight, which aims to transform the moments of child
healthcare in a time of relation (between mother and kid) peaceful,
simple and safe in order to get parents’ confidence and smiling babies.
Halykoo is the first and only OTC pediatric healthcare brand that
matches formulations specifically focused on each of the unique ages and
stages of children’s growth, since birth, with smart and innovative
formulations and delivery systems intended to simplify their use for
parents and reduce the hassle for babies.
Halykoo products are the perfect combination of responsible, Swiss,
high-quality research combined with an extensive understanding of child
and caregivers needs: as a result, each Halykoo product provides the
right formula – from accurate selection of the ingredients (including
natural BIO certified components), to careful dosing of the active
principles and full compliance with the strictest safety standards – and
the right delivery system for the right age.
For more info about Halykoo, please visit: http://www.halykoo.com
About Hao Le Ku (Beijing) Infant and Materniity Co., Ltd.
Our
company is engaged in marketing of baby products. We are a service
oriented, high quality and ethically-driven company. Our company was
founded in 2013 and registered in Tian Jin, China. Our revenue has been
increased dramatically during past 2 years. Our growth rate is more than
100%. Our baby protection product has been covered in many different
categories in the industry.
About APR Applied Pharma Research s.a.
APR is an independent
Swiss company, specialized in the development of science-driven,
patent-protected healthcare products. The Company identifies, develops
and licenses science- driven, value-added products designed to address
patient or consumer needs in selected therapeutic areas on a global
basis. Specifically, APR is currently focused on 2 (two) major areas:
(i) internally developed and financed (alone or with our co-development
partners) proprietary, value-added products to be licensed to healthcare
companies for their commercialization, and (ii) support to third-party
projects, by offering value-added, R&D services under contract and fee
for service arrangements. APR has a balanced pipeline of
revenue-generating branded products marketed in all major markets,
combined with a compelling pipeline of products at different development
stages. APR has entered into licensing and partnership agreements with
pharmaceutical companies in over 70 countries, with international sales
on a worldwide basis. For more info, please visit: http://www.apr.ch.
Contacts
APR Applied Pharma Research s.a.
Paolo Galfetti, T: +41 91
6957020
Chief Executive Officer
Email: paolo.galfetti@apr.ch
or
Hao
Le Ku (Beijing) Infant and Materniity Co., Ltd.
Joshua Hua,
Phone :+(86) 022-28389361
Fax : +(86) 022-28389361
Business
Development Director
Email : huayx@hualongkang.com
